Review explores the links between obesity, type 2 diabetes, and osteoarthritis, focusing on the impact of ectopic (intra-abdominal) fat distribution on disease pathogenesis and progression, with implications for targeted interventions and multidisciplinary management approaches.
Februery 2022
Participants in obesity management programs experience weight loss and improvements in anxiety, depression, and blood pressure, highlighting the importance of addressing emotional well-being alongside physical health outcomes in individuals living with obesity.
January 2022
Emergency use authorization for nitazoxanide as a potential treatment for COVID-19 is requested from the FDA in the US, signaling ongoing efforts to repurpose existing drugs for combating the pandemic and expanding therapeutic options for affected individuals.
January 2022
Patients with obesity have a 30% higher risk of hospital admission for long-term complications of COVID-19, highlighting the need for targeted interventions and public health initiatives to mitigate disparities and improve outcomes in vulnerable populations.
December 2021
Following reports of rare blood clotting events, the FDA and CDC recommend a pause in the use of the Johnson & Johnson vaccine, highlighting the importance of post-authorization safety monitoring and rapid response to vaccine-related adverse events.
December 2021
The adverse consequences attributed to obesity may be mediated by hyperinsulinemia, suggesting a complex interplay between metabolic and hormonal factors in obesity-related complications and underscoring the importance of targeted interventions in managing obesity-related health risks.
November 2021
Physical activity may prompt increased food intake, posing challenges to weight loss efforts, understanding underlying mechanisms and implementing strategies to mitigate compensatory eating behaviors are crucial for achieving sustainable weight management goals.
November 2021